AFFF cancer lawsuit

Military Firefighters And Others Have Relied On AFFF To Fight Chemical And Jet Fuel Fires since the 1970s

Now it is widely accepted that many of its ingredients cause cancer in humans

Sunday, April 7, 2024 - Aqueous Film Forming Foam (AFFF) is a vital aid in the fight against flames, particularly when battling Class B fires, or high-intensity fires containing flammable liquids and gases. Because of its exceptional fire-suppressive qualities, AFFF has been widely employed by firemen, military personnel, and industrial settings since its creation in the 1960s and its broad use in the 1970s. By establishing a barrier between the fuel and the air, the foam efficiently puts out the fire and stops flammable gasses from escaping. When standard water-based approaches failed, AFFF proved to be an invaluable resource due to its rapid extinguishment of difficult fires and ability to keep them from rekindling. This applies to aircraft and maritime fires as well, where prompt action is essential to preserving human life and reducing property damage. But the contents of AFFF--a concoction of water, solvents, stabilizers, and fluorosurfactants (such PFAS, or perfluoroalkyl and poly-fluoroalkyl substances)--have grown to be a serious health and environmental hazard. PFAS chemicals, in particular, have been linked to several major health problems, including cancer, according to studies and examinations of the chemical components of AFFF. A class of synthetic compounds known as PFAS has been utilized for many years in consumer goods and industrial uses. The fact that they do not degrade and can build up over time makes them known as "forever chemicals" in both the environment and the human body.

Scientific evidence has been mounting in support AFFF lawsuits regarding the link between cancer and exposure to PFAS compounds. Research has revealed links between exposure to per- and poly-fluoroalkyl substances of t (PFAS) and multiple cancer forms, such as non-Hodgkin's lymphoma, kidney cancer, and testicular cancer. Because AFFF is used in emergency response scenarios and training, firefighters and military personnel have historically been exposed to high concentrations of these chemicals, making their concerns especially pressing. The toxicological consequences of AFFF components have been discovered, and this has prompted important legal and regulatory activities. Numerous firefighters and veterans of the armed forces have sued AFFF makers, claiming that the businesses were aware of the risks associated with PFAS but neglected to alert consumers. These court cases demonstrate the public's increasing awareness of health concerns and their desire for accountability. Growing evidence of health risks has prompted calls for stronger laws governing the use of PFAS and the creation of safer substitutes for AFFF. Some states in the US and other nations have started to phase out the use of AFFF which contains PFAS to encourage the use of fluorine-free foams, which have comparable firefighting capabilities without hazards to human health. A major change in firefighting techniques, the switch from AFFF to safer substitutes is indicative of a larger trend towards environmental stewardship and public health protection. The history of AFFF serves as a reminder of the necessity for careful knowledge and regulation of chemical ingredients, even while research into safe and effective firefighting foams continues.

Information provided by AFFFLawsuitCenter.com, a website devoted to providing news about AFFF and PFAS cancer, lymphoma and leukaemia claims, including a free no-cost, no-obligation AFFF Lawsuit Claim.

More Recent AFFF Lawsuit News:

View all AFFF Lawsuit News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer, Lymphoma or Leukaemia After Exposure to Firefighting Foam

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.